CDK4/6 Inhibitors in Melanoma: A Comprehensive Review

by Garutti, Mattia, Targato, Giada, Buriolla, Silvia, Palmero, Lorenza, Minisini, Alessandro Marco, Puglisi, Fabio
Published in Cells (2021)

Find the Flame: Predictive Biomarkers for Immunotherapy in Melanoma

by Garutti, Mattia, Bonin, Serena, Buriolla, Silvia, Bertoli, Elisa, Pizzichetta, Maria Antonietta, Zalaudek, Iris, Puglisi, Fabio
Published in Cancers (Basel) (2021)

“To Anticipate”: Neoadjuvant Therapy in Melanoma with a Focus on Predictive Biomarkers

by Garutti, Mattia, Buriolla, Silvia, Bertoli, Elisa, Vitale, Maria Grazia, Rossi, Ernesto, Schinzari, Giovanni, Minisini, Alessandro Marco, Puglisi, Fabio
Published in Cancers (Basel) (2020)

Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

by Gerratana, Lorenzo, Basile, Debora, Franzoni, Alessandra, Allegri, Lorenzo, Viotto, Davide, Corvaja, Carla, Bortot, Lucia, Bertoli, Elisa, Buriolla, Silvia, Targato, Giada, Da Ros, Lucia, Russo, Stefania, Bonotto, Marta, Belletti, Barbara, Baldassarre, Gustavo, Damante, Giuseppe, Puglisi, Fabio
Published in Front Oncol (2020)

First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study

by Basile, Debora, Gerratana, Lorenzo, Corvaja, Carla, Pelizzari, Giacomo, Franceschin, Giorgia, Bertoli, Elisa, Palmero, Lorenza, Zara, Diego, Alberti, Martina, Buriolla, Silvia, Da Ros, Lucia, Bonotto, Marta, Mansutti, Mauro, Spazzapan, Simon, Cinausero, Marika, Minisini, Alessandro Marco, Fasola, Gianpiero, Puglisi, Fabio
Published in Breast (2021)